Journal of Reproduction & Infertility

Journal of Reproduction & Infertility

Treatment of Immature Teratoma Associated with Ovarian Endometrioma: A Case Report

Authors
1 Department of Obstetrics and Gynecology, Firouzgar Hospital, Iran University of Medical Sciences, Tehran, Iran
2 Department of Pathology, Jam Hospital, Tehran, Iran
Abstract
Background: Mature teratoma is a benign neoplasm, mostly composed of well-differentiated derivations of almost two or three germ cell layers, while immature teratoma is a malignant neoplasm composed of immature neural and embryonic tissue. Immature teratoma in the context of ovarian endometrioma has not been reported yet. Case Presentation: A 34-year-old woman with primary infertility is reported in this study who suffered from immature teratoma associated with ovarian endometrioma. After several rounds of fertility treatment, the patient was referred for severe abdominal pain and underwent emergency surgery for the rupture of ovarian endometrioma. To preserve the ovary, the cyst was not resected in areas attached to the ovary. Some months later, the patient noticed a progressive abdominal enlargement. The sonographic evaluation revealed multiple solid-cystic lobulated masses on the abdominal wall and throughout the pelvic cavity. The histologic diagnosis was consistent with immature teratoma. The patient was treated with high-dose neoadjuvant chemotherapy and fertility-sparing surgery (FSS). The histologic evaluation of the extracted masses revealed teratoma maturation. Conclusion: This study reveals the importance of complete removal of endometrioma and highlights the role of neoadjuvant chemotherapy in fertility-sparing surgery and potentiating teratoma maturation.
Keywords

  1. Matalliotakis M, Matalliotaki C, Zervou MI, Krithinakis K, Goulielmos GN, Kalogiannidis I, et al. Retrospective evaluation of pathological results among women with ovarian endometriomas versus teratomas. Mol Clin Oncol. 2019;10(6):592-6.
  2. Schmidt D, Kommoss F. [Teratoma of the ovary. clinical and pathological differences between mature and immature teratomas]. Pathologe. 2007;28(3):203-8. Germany.
  3. Donadio AC, Motzer RJ, Bajorin DF, Kantoff PW, Sheinfeld J, Houldsworth J, et al. Chemotherapy for teratoma with malignant transformation. J Clin Oncol. 2003;21(23):4285-91.
  4. Imran H, Siddiqui AH, Wilson F, Pashankar F. Growing teratoma syndrome After chemotherapy for ovarian immature teratoma. J Pediatr Hematol Oncol. 2020;42(7):e630-3.
  5. Vasta FM, Dellino M, Bergamini A, Gargano G, Paradiso A, Loizzi V, et al. Reproductive outcomes and fertility preservation strategies in women with malignant ovarian germ cell tumors after fertility sparing surgery. Biomedicines. 2020;8(12):544.
  6. Der EM, Seidu S. Case report of three immature cystic teratomas in northern Ghana. Case Rep Obstet Gynecol. 2019;2019:1210509.
  7. Takagi H, Takata E, Sakamoto J, Fujita S, Takakura M, Sasagawa T. Malignant transformation of an ovarian endometrioma during endometriosis treatment: a case report. Case Rep Obstet Gynecol. 2018;2018:6210172.
  8. Li J, Wu X. Current strategy for the treatment of ovarian germ cell tumors: role of extensive surgery. Curr Treat Options Oncol. 2016;17(8):44.
  9. Pashankar F, Hale JP, Dang H, Krailo M, Brady WE, Rodriguez-Galindo C, et al. Is adjuvant chemotherapy indicated in ovarian immature teratomas? a combined data analysis from the malignant germ cell tumor international collaborative. Cancer. 2016;122(2):230-7.
  10. Talukdar S, Kumar S, Bhatla N, Mathur S, Thulkar S, Kumar L. Neo-adjuvant chemotherapy in the treatment of advanced malignant germ cell tumors of ovary. Gynecol Oncol. 2014;132(1):28-32.
  11. Gorbatiy V, Spiess PE, Pisters LL. The growing teratoma syndrome: current review of the literature. Indian J Urol. 2009;25(2):186-9.
  12. Sato S, Itamochi H. Neoadjuvant chemotherapy in advanced ovarian cancer: latest results and place in therapy. The Adv Med Oncol. 2014;6(6):293-304.
  13. Culine S, Lhomme C, Kattan J, Michel G, Duvillard P, Droz J. Pure malignant immature teratoma of the ovary: the role of chemotherapy and second-look surgery. Int J Gynecol Cancer. 1995;5(6):432-7.